Clinical Trials Update provides you with latest news about clinical trials conducted by MVA member companies. The update gives insight to progress in studies, results and possible indications.   

Active Biotech Advances ANYARA into Phase III Clinical Trial

13 May - Active Biotech has decided to proceed with ANYARA into the pivotal phase III to further evaluate the effect for treatment of renal cell carcinoma. The primary endpoint is overall survival.

Read more